Mission
To transform translational neuroscience by strengthening the scientific, ethical, and strategic pillars of neuropathology, elevating veterinary science, inclusive mentorship, and forward-thinking initiatives.
About Us
We reimagine translational neuropathology through science, ethics, and innovation.
Vision
To become a global benchmark where veterinary, human, and quantum perspectives converge to accelerate discovery and inspire a new generation of scientific leadership.
Our Approach – Rethinking Translational Science
- 🔹 Scientific precision & ethical leadership
- 🔹 Veterinary insight with real translational impact
- 🔹 Pathology, technology & emerging diagnostics
Meet the Founders
Edna Gómez
Founder & Scientific Director
Veterinary medical doctor, PhD in Investigative Pathology. Expertise in translational neuropathology, brain injury models and chronic stress.
“I founded NPBC to bridge a dangerous gap in preclinical research where animal science is often overlooked and reproducibility is at stake.”
Cristian Gómez
Co-Founder · Strategic & Operations Advisor
Economist, MSc in Urban & Regional Planning. Strategic planning, project management and research optimization.
“I joined NPBC to turn deep scientific expertise into real-world solutions through ethical and scalable strategies.”
Why NPBC?
- ✅ We enhance experimental neuroscience beyond conventional models.
- ✅ We foster ethical mentorship and the 3Rs (Replacement, Reduction, Refinement).
- ✅ We explore cutting-edge diagnostic strategies grounded in quantum and molecular insights.
- ✅ We connect disciplines to achieve meaningful translational outcomes.
Integrity & Legal Framework
We uphold research integrity, promote the 3Rs and protect the well-being of animal models and professionals.
NeuroPath BioConsulting S.A.S. (NPBC) — NIT 901943323-9, Commercial Registry No. 415122, Colombia.